Open AccessAddition of Biphasic, Prandial, or Basal Insulin to Oral Therapy in Type 2 Diabetes
Author(s) -
Rury R. Holman,
Kerensa Thorne,
Andrew Farmer,
Melanie J. Davies,
Joanne F. Keenan,
Sanjoy K. Paul,
J Levý
Publication year - 2007
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa075392
Subject(s) - medicine , glycated hemoglobin , glycemic , insulin detemir , insulin aspart , hypoglycemia , insulin , metformin , endocrinology , diabetes mellitus , hemoglobin , type 2 diabetes , basal (medicine) , sulfonylurea , gastroenterology , insulin glargine
Adding insulin to oral therapy in type 2 diabetes mellitus is customary when glycemic control is suboptimal, though evidence supporting specific insulin regimens is limited.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom